Among them, C‐MYC (further called MYC) has the strongest oncogenic potential and is widely deregulated in cancer, while N‐MYC and L‐MYC are mainly involved in neuroblastoma and lung cancer, respectively [3, 4, 5]. The gene discussed is MYC; the disease is cancer.